SCHEMBL6922101

SCHEMBL6922101

CC(C)c1ccc(C(=O)Nc2ccc(OCCN(C(C)C)C(C)C)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 12/20 0.75
EGFR P00533 1/20 0.56
ERBB2 P04626 1/20 0.56
KDM4E B2RXH2 3/20 0.54
LMNA P02545 2/20 0.54
MAPT P10636 2/20 0.53
RAB9A P51151 2/20 0.53
ALDH1A1 P00352 2/20 0.53
TSHR P16473 1/20 0.53
MCL1 Q07820 1/20 0.53
HSD17B10 Q99714 1/20 0.53
HTR2C P28335 1/20 0.53
NPC1 O15118 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TP53 P04637 1/20 0.51
ESR1 P03372 1/20 0.51
ESR2 Q92731 1/20 0.51
STAT3 P40763 1/20 0.49
CYP1A2 P05177 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6922691 0.88 MCHR1 (0.75) MCHR1KDM4EMAPTRAB9AALDH1A1
SCHEMBL6927755 0.88 MCHR1 (0.75) MCHR1KDM4ELMNAMAPTRAB9A
SCHEMBL6926388 0.87 MCHR1 (0.73) MCHR1KDM4ELMNAMAPTRAB9A
SCHEMBL6921877 0.87 MCHR1 (0.71) MCHR1EGFRERBB2KDM4ELMNA
SCHEMBL6807981 0.86 MCHR1 (0.83) MCHR1RAB9AHTR2CNPC1SMN1; SMN2
SCHEMBL6803781 0.86 MCHR1 (1.00) MCHR1HTR2C
SCHEMBL6801515 0.84 MCHR1 (0.80) MCHR1LMNARAB9AHTR2CNPC1
SCHEMBL6929018 0.84 MCHR1 (0.80) MCHR1KDM4ELMNAMAPTRAB9A
SCHEMBL6920748 0.82 MCHR1 (0.71) MCHR1RAB9AALDH1A1HTR2CNPC1
SCHEMBL6812487 0.81 MCHR1 (0.73) MCHR1LMNAMAPTHTR2CESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515027-B1 Ligands, agonists or antagonists, of the CC chemokine receptor CC-CKR5 SMITHKLINE BEECHAM CORP. 2003-02-04 US disclosed
EP-1001766-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2001-04-04 EP disclosed
EP-1001766-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-05-24 EP disclosed
WO-1999001127-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 1999-01-14 WO disclosed